Raza Bokhari - 16 Dec 2025 Form 4 Insider Report for Medicus Pharma Ltd. (MDCX)

Role
Chief Executive Officer, Director
Signature
/s/ Raza Bokhari
Issuer symbol
MDCX
Transactions as of
16 Dec 2025
Net transactions value
$0
Form type
4
Filing time
18 Dec 2025, 16:06:55 UTC
Previous filing
24 Jul 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Bokhari Raza Chief Executive Officer, Director 300 CONSHOHOCKEN STATE ROAD, SUITE 200, W. CONSHOHOCKEN /s/ Raza Bokhari 18 Dec 2025 0001660525

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MDCX Stock Option (right to buy) Award $0 +125,000 $0.000000 125,000 16 Dec 2025 Common Shares 125,000 $1.80 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted on December 16, 2025. The option is scheduled to vest quarterly in four equal installments over one year.